Human Clinical Trial
Official title:
Adding Antioxidants Into Human Embryo Culture Media
Aim: To investigate the impact of antioxidants (acetyl-L-carnitine, N-acetyl-L-cysteine and
a-lipoic acid) on embryo development and subsequently the clinical outcome. Including clinics
using low oxygen and ambient air during embryo culture. Analysed with time-lapse system.
Study media: G-TL with antioxidants. Control media: Same media without antioxidants. Type of
study: Study comparing blastocyst development on the same cohort of oocytes using two
different media, G-TL versus G-TL supplemented with antioxidants. Statistics based on an
absolute increase in Good Quality Blastocysts on day 5 of 7%.
Design: Multicentre prospective randomized sibling trial. Single blastocyst transfer.
Superiority study Primary Endpoint: Good Quality Blastocysts on day 5 per allocated normally
fertilized oocyte.
Patients: Comparative embryo sibling study with 128 patients included.
Study objective: Study comparing blastocyst development on the same cohort of oocytes using
two different media, G-TL versus G-TL supplemented with antioxidants.
Primary endpoint: Percentage of good quality blastocysts (GQB) per fertilized oocyte on day
5.
Secondary endpoints
- Embryo development day 3, 5 and 6
- Embryo quality day 3, 5 and 6
- Total blastocyst formation (day 5 and day 6)
- Utilization rate (embryos available for transfer and cryopreservation)
- Implantation rate
- Clinical pregnancy rate
Setup: Prospective embryo sibling, superiority study
MATERIALS AND METHODS Intervention New type of embryo culture media used for in vitro culture
of human IVF embryos.
Power analysis The planning and the power analysis was made together with a statistician,
Nils-Gunnar Pehrsson.
From retrospective data using simulation, the intra individual SD for the difference in % GQB
between the two media strategies was estimated to 32%. In order to find a difference in 8% in
GQB between the two media with power 80% with paired T-test 128 couples will be needed.
Randomization Couples will be enrolled in the study after fertilization check (day 1). A
minimum of 6 zygotes is required for participation.
Stratified randomization of the zygotes by couple will be performed. For each couple the
zygotes will be numbered.
These zygotes for each couple will then be block (by two) randomized to the two media types;
A (Traditional culture media = Control) and B (Antioxidant media = intervention). In both
groups traditional culture will be performed. Allocation will be performed in a 1:1 ratio
according to a unique randomization list for each couple.
Blinding To minimize possible bias for the primary outcome (GQE D5) the embryologist
performing the morphological evaluation on day 5/6 will not know which group the embryos
belong to.
Both the physician and the couple will be blinded to which group they have been allocated.
IVF treatment procedure A traditional IVF treatment will be performed including ovarian
stimulation and oocyte pick-up using the standard methods at the clinics.
Embryo assessment and timing of assessment according to Alpha/ESHRE consensus criteria.
Morphological scoring Blastocyst morphology will be scored according to Consensus Scoring
system for blastocysts (Istanbul Consensus workshop on embryo assessment) and the morphology
will be documented with individual photos of each blastocyst. Blastocyst scoring will be
performed under an inverted microscope on day 5 and day 6. A good quality blastocyst is
defined as at least Grade 2:2:2 according to Istanbul Consensus grading system. (Balaban et
al., 2011).
DOCUMENTATION All patients participating in the study will be documented on a computerized
CRF. This document will be related to patients' records with all relevant clinical and
laboratory data from the specific IVF cycle. Through the journal system (WinIVF) used at
Fertilitetscentrum, it will be possible to generate a complete list of all the variables
included in the study.
Patients who have been asked to participate in the study but did not fulfill the criteria for
randomization will also be registered.
STATISTICAL ANALYSIS Both an Intention-to-Treat (ITT) population and a Per Protocol (PP)
population will be defined. Primary efficacy variable in this superiority study will be
difference in %GQB between the two media types for each couple. Primary statistical analysis
will be two-sided paired T-test regarding the mean of difference in %GQB between Standard
culture media and Antioxidant media on the ITT population. A two sided 95% confidence
interval for the mean difference in %GOB between the two media will be calculated. All
significance tests will be two-sided and conducted at the 5% significance level.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04074928 -
Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects
|
Phase 3 | |
Recruiting |
NCT03675464 -
Study of Human Adipose Tissue (LOSHAT)
|
||
Recruiting |
NCT06042348 -
Placenta Perfusion and Sufficiency Study
|
||
Completed |
NCT04576702 -
Safety and Immunogenicity of an MF59-Adjuvanted Influenza Vaccine in Older Adults
|
Phase 2 | |
Completed |
NCT00092547 -
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
|
Phase 3 | |
Recruiting |
NCT02589899 -
Monitoring of Needle-placement With Multiple Frequency Bioimpedance Monitoring
|
N/A | |
Not yet recruiting |
NCT01943565 -
Intrathecal Hydromorphone for Post-cesarean Delivery Pain - a Dose Finding Study
|
Phase 4 | |
Completed |
NCT01455753 -
The Effect of Proximity on Flu-Shot Participation
|
N/A | |
Recruiting |
NCT05964725 -
The Study on Effect and Neural Network Mechanism of Transcranial Direct Current Stimulation for Sudden Deafness With Tinnitus
|
N/A | |
Completed |
NCT04443231 -
Prospective Clinical Study of Retinal Microvascular Alteration After ICL Implantation
|
||
Completed |
NCT03060161 -
Health in the Right Measure: Promoting Healthy Food and Regular Physical Activity Practice for UFRJ Servers
|
N/A | |
Recruiting |
NCT04613583 -
Scottish Advanced Fetal Research Study
|
||
Completed |
NCT01640327 -
Safety and Immunogenicity of One Dose of Seasonal Trivalent Influenza Virus Vaccine (TIVf, Purified Surface Antigen, Inactivated, Egg Derived) in Adults Aged 18 Years and Above
|
Phase 3 | |
Completed |
NCT03240601 -
Spinal Cord Stimulation to Augment Activity Based Therapy
|
N/A | |
Terminated |
NCT05210387 -
Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections
|
N/A | |
Recruiting |
NCT05703607 -
A Study to Learn About a Modified RNA Vaccine Against Shingles in Healthy Adults
|
Phase 2 | |
Completed |
NCT02999958 -
Adding Antioxidants Into Human Sequential Culture Media System
|
N/A | |
Completed |
NCT03153436 -
The Effect of In-vitro Myoinositol Supplementation of Human Sperm on the Outcome of Cryopreservation
|
Phase 1/Phase 2 | |
Active, not recruiting |
NCT05081960 -
Evaluating the Vitamin K2 Status of Calcium-based Stone Formers
|
||
Recruiting |
NCT05843084 -
The STEREO-DBS Study: 7-Tesla MRI Brain Network Analysis for Deep Brain Stimulation
|